ANI Pharmaceuticals, Inc. Financial Ratios — ANIP Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	-181.2	-84.01	-13.52	31.81	10.25	2.39	-0.62	8.33	2.97	-11.04	-16.16	-15.29	4.6	-4.82	16.34
Return on Assets (%)	-96.33	-54.81	0.72	18.91	5.64	1.29	-0.29	3.68	1.37	-4.91	-6.91	-6.25	2.26	-1.69	5.75
Return on Capital (%)	- -	- -	1.8	- -	8.91	3.22	-0.56	7.11	- -	- -	- -	- -	6.47	- -	8.57
Return on Invested Capital (%)	- -	- -	2.1	- -	9.22	4.66	-0.64	8.05	- -	- -	- -	- -	8.37	- -	6.92
Gross Margin (%)	88.51	100	66.84	79.5	83.37	62.07	55.31	63.77	69.42	58.19	53.45	56.13	62.71	59.27	61.36
EBITDA Margin (%)	-11,668.95	-995.88	6.68	42.67	51.89	38.18	32.32	34.28	29.55	13.94	8.83	10.72	22.46	11.39	19.54
Operating Margin (%)	-11,703.01	-1,007.14	2.99	35.74	42.84	20.81	16.53	17.54	7.95	-7.47	-13.03	-8.13	10.17	0.36	9.2
Incremental Operating Margin (%)	- -	- -	86.64	73.81	62.37	-11.35	5.12	24.77	-380.87	- -	- -	- -	44.16	-37.09	29.37
Pretax Margin (%)	-11,859.66	-1,210.03	0.42	34.62	28.48	6.75	9.24	9.95	1.53	-12.45	-25.94	-19.81	4.08	-3.62	10.84
Profit Margin (%)	-11,859.66	-1,204.73	1	51.36	20.14	3.06	-0.61	7.69	2.95	-10.82	-19.71	-15.14	3.86	-3.01	8.87
Net Income to Common Margin (%)	-11,859.66	-1,204.73	-15.54	51.36	20.14	3.06	-0.61	7.69	2.95	-10.82	-19.8	-15.65	3.52	-3.28	8.74
Effective Tax Rate (%)	- -	- -	15.87	- -	29.26	54.67	106.58	22.73	- -	- -	- -	- -	5.5	- -	18.22
Dvd Payout Ratio (%)	- -	- -	102.18	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	-181.2	-84.01	0.29	31.81	10.25	2.39	-0.62	8.33	2.97	-11.04	-16.16	-15.29	4.6	-4.82	16.34

Credit (USD)

Credit Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	17	8	- -	107	113	121	202	183	186	186	287	287	286	624	617
ST Debt	- -	8	- -	- -	- -	- -	3	116	10	13	1	1	1	9	17
LT Debt	17	- -	- -	107	113	121	198	67	176	172	287	286	285	615	600
Total Debt/EBITDA	-0.34	-0.34	- -	4.46	2.86	2.46	3.53	2.65	3.04	6.39	15.06	8.45	2.61	8.92	3.57
Net Debt/EBITDA	0.79	1.17	-5.53	-2.62	-1.04	1.9	2.98	2.03	2.02	6.12	9.8	7.03	0.59	6.85	1.92
Total Debt/EBIT	-0.34	-0.34	- -	5.33	3.47	4.51	6.89	5.18	11.31	-11.93	-10.2	-11.13	5.77	281.38	7.6
Net Debt/EBIT	0.78	1.16	-12.37	-3.12	-1.26	3.49	5.83	3.96	7.51	-11.42	-6.64	-9.26	1.3	216.06	4.08
EBITDA to Interest Expense	-74.5	-65.84	4.3	30.35	3.6	4.34	4.75	4.68	4.71	3.08	1.6	1.21	4.06	3.97	8.61
EBITDA-CapEx/Interest Expense	-75.56	-67.59	3.89	-15.08	0.63	-8.82	-4.22	3.94	2.58	-4.15	-0.38	0.62	3.37	3.01	6.9
EBIT to Interest Expense	-74.72	-66.58	1.92	25.42	2.97	2.36	2.43	2.4	1.27	-1.65	-2.36	-0.92	1.84	0.13	4.05
Interest Expense	1	- -	- -	1	11	11	12	15	13	9	12	28	27	18	20
Common Equity/Total Assets	60.62	72.67	92.05	53.86	56.12	52.54	42.4	45.81	46.58	42.43	43.27	41.27	47.85	31.43	37.54
Long-Term Debt/Equity (%)	45.85	- -	- -	76.22	70.86	71.11	113.39	34.11	82.62	88.12	79.87	84.38	62.24	143.5	110.92
Long-Term Debt/Capital (%)	31.43	- -	- -	43.25	41.47	41.56	52.66	17.7	44.11	45.21	44.35	45.7	38.32	58.42	51.8
Long-Term Debt/Total Assets (%)	27.79	- -	- -	41.05	39.76	37.37	48.08	15.63	38.49	37.39	37.13	37.58	31.49	47.87	41.64
Total Debt/Equity (%)	45.85	27.98	- -	76.22	70.86	71.11	115.31	92.78	87.29	94.88	80.11	84.63	62.43	145.64	114.11
Total Debt/Capital (%)	31.43	21.86	- -	43.25	41.47	41.56	53.55	48.13	46.61	48.69	44.48	45.84	38.43	59.29	53.3
Total Debt/Total Assets (%)	27.79	20.34	- -	41.05	39.76	37.37	48.89	42.5	40.66	40.26	37.24	37.7	31.59	48.59	42.84
Net Debt to Equity	-105.48	-95.51	-27.11	-44.71	-25.77	54.98	97.49	70.97	58	90.86	52.15	70.39	14.11	111.83	61.3
Net Debt/Capital (%)	1,924.02	-2,127.22	-37.19	-80.86	-34.72	35.48	49.36	41.51	36.71	47.61	34.27	41.31	12.36	52.79	38
EBITDA	-51	-23	2	24	40	49	57	69	61	29	19	34	109	70	173
EBITDA-CapEx	-51	-24	2	-12	7	-100	-51	58	33	-39	-5	17	91	53	138
Operating Income (Loss)	-51	-23	1	20	33	27	29	35	16	-16	-28	-26	50	2	81

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	7.92	3.28	3.14	12.77	13.16	0.86	0.79	0.26	1.01	0.1	1.15	0.49	1.52	0.78	1.06
Current Ratio	8.03	3.32	7.83	14.74	16.38	3.22	3.35	0.92	3.04	2.17	3.68	3.46	3.57	2.72	2.71
Quick Ratio	7.92	3.28	6.68	14.08	15.02	2.29	2.29	0.65	2.18	1.32	2.61	2.15	2.63	1.92	2.07
CFO/Avg Current Liab	-6.21	-2.84	-0.78	2.63	1.38	1.26	1.11	0.66	0.4	0.22	0.04	-0.33	0.97	0.38	0.78
Common Equity/Total Assets	60.62	72.67	92.05	53.86	56.12	52.54	42.4	45.81	46.58	42.43	43.27	41.27	47.85	31.43	37.54
Long-Term Debt/Equity (%)	45.85	- -	- -	76.22	70.86	71.11	113.39	34.11	82.62	88.12	79.87	84.38	62.24	143.5	110.92
Long-Term Debt/Capital (%)	31.43	- -	- -	43.25	41.47	41.56	52.66	17.7	44.11	45.21	44.35	45.7	38.32	58.42	51.8
Long-Term Debt/Total Assets (%)	27.79	- -	- -	41.05	39.76	37.37	48.08	15.63	38.49	37.39	37.13	37.58	31.49	47.87	41.64
Total Debt/Equity (%)	45.85	27.98	- -	76.22	70.86	71.11	115.31	92.78	87.29	94.88	80.11	84.63	62.43	145.64	114.11
Total Debt/Capital (%)	31.43	21.86	- -	43.25	41.47	41.56	53.55	48.13	46.61	48.69	44.48	45.84	38.43	59.29	53.3
Total Debt/Total Assets (%)	27.79	20.34	- -	41.05	39.76	37.37	48.89	42.5	40.66	40.26	37.24	37.7	31.59	48.59	42.84
CFO/Total Liabilities	-194.88	-238.66	-155	18.4	13.79	17.93	16.61	28.75	18.7	5.75	0.8	-7.4	26.62	7.48	20.59
CFO/CapEx	-66.49	-41.37	-28.71	0.62	0.53	0.18	0.37	6.15	1.66	0.22	0.14	-1.9	6.43	3.78	5.4
Altman's Z-Score	-5.25	-8.3	32.58	4.67	4.31	4.8	4	2.79	3.43	1.78	1.88	1.81	3	2.11	3.06

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	- -	- -	4.81	3.76	3.89	3.79	3.38	3.26	3.02	2.48	1.93	2.15	2.97	3.2	3.51
Days Sales Outstanding	- -	- -	75.91	97.2	93.8	96.24	108.03	111.93	121.02	147	189.41	169.57	122.78	114.01	103.88
Inventory Turnover	- -	- -	5.67	2.08	1.21	2.47	2.47	1.87	1.42	1.6	1.41	1.48	1.68	2.02	2.44
Days Inventory Outstanding	- -	- -	64.37	175.55	300.6	148.04	147.58	195.51	256.22	228.17	258.48	245.97	217.73	180.87	149.64
Accounts Payable Turnover	0.01	- -	10.55	7.58	7.86	22.58	25.81	12.11	6.03	7.72	7.1	6.22	5.68	6.7	6.42
Accounts Payable Turnover Days	29,254.36	- -	34.6	48.16	46.41	16.17	14.14	30.13	60.54	47.3	51.41	58.72	64.28	54.49	56.83
Cash Conversion Cycle	-29,254.36	- -	105.69	224.59	347.99	228.11	241.47	277.31	316.71	327.86	396.48	356.81	276.23	240.4	196.69
Inventory to Cash Days	- -	- -	11.54	-78.35	-206.79	-51.8	-39.55	-83.58	-135.2	-81.17	-69.07	-76.4	-94.95	-66.86	-45.76
Inventories	- -	- -	4	8	13	26	38	41	48	61	82	105	111	137	143
Raw Materials	- -	- -	1	5	10	14	22	28	35	42	51	68	62	67	74
Work In Process	- -	- -	- -	- -	- -	- -	1	1	- -	1	1	2	3	2	3
Finished Goods	- -	- -	1	1	2	11	14	11	17	20	32	28	36	58	56
Other Inventory	- -	- -	1	1	1	1	2	3	3	3	5	18	10	10	10

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	55	30	193	642	519	703	751	534	746	359	776	704	1,129	1,167	1,775
- Cash & Cash Equivalents	57	35	11	169	155	27	31	43	62	8	100	48	221	145	286
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	25	25	25	25	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	17	8	- -	107	113	121	202	183	186	186	287	287	286	624	617
Enterprise Value	15	3	182	580	478	796	921	674	869	537	987	967	1,218	1,665	2,098
Total Capital	55	36	41	246	274	290	376	380	399	381	646	625	743	1,053	1,158
Total Debt/Capital (%)	31.43	21.86	- -	43.25	41.47	41.56	53.55	48.13	46.61	48.69	44.48	45.84	38.43	59.29	53.3
Total Debt / EV	1.16	2.52	- -	0.18	0.24	0.15	0.22	0.27	0.21	0.35	0.29	0.3	0.23	0.37	0.29
EV/Sales	34.29	1.36	6.05	10.36	6.26	6.19	5.21	3.34	4.21	2.57	4.57	3.06	2.5	2.71	2.37
EV/EBITDA	- -	- -	90.67	24.27	12.06	16.21	16.12	9.75	14.24	18.46	51.74	28.51	11.14	23.8	12.15
EV/EBIT	- -	- -	202.74	28.97	14.61	29.73	31.51	19.05	52.9	- -	- -	- -	24.59	750.51	25.83
EV/Cash Flow to Firm	- -	- -	- -	24.99	19.06	24.41	23.85	8.58	12.3	22.86	79.74	- -	8.43	21.15	10.4
EV/Free Cash Flow to Firm	- -	- -	- -	9.83	8.27	4.38	6.28	7.54	8.85	5.85	27.41	144.48	7.48	17.4	8.89
Diluted Market Cap	49	27	102	623	522	702	744	530	743	347	580	654	1,003	1,068	1,676
Diluted Enterprise Value	9	- -	91	561	480	795	915	670	866	525	792	917	1,093	1,572	2,007
EV per Share	4.9	0.77	18.93	50.9	41.54	68.67	79.07	56.83	71.88	43.43	58.67	55.27	59.51	78.86	93.27
TTM Sales	- -	2	30	56	76	129	177	202	207	208	216	316	487	614	883
TTM EBITDA	-51	-23	2	24	40	49	57	69	61	29	19	34	109	70	173
TTM Operating Income	-51	-23	1	20	33	27	29	35	16	-16	-28	-26	50	2	81
TTM Cash Flow to Firm	-47	-25	-5	23	25	33	39	78	71	23	12	-10	144	79	202
TTM Free Cash Flow to Firm	-46	-24	-5	59	58	182	147	89	98	92	36	7	163	96	236

Multiples (USD)

Valuation Multiples API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	-1.04	-1.08	-19.24	10.79	10.44	3.97	5.05	6.8	10.15	4.16	21.53	-44.35	7.3	13.19	7.63
EV/EBIT	- -	- -	202.74	28.97	14.61	29.73	31.51	19.05	52.9	- -	- -	- -	24.59	750.51	25.83
Enterprise Value	15	3	182	580	478	796	921	674	869	537	987	967	1,218	1,665	2,098
Low Price	13.68	6.48	4.8	18.52	36.15	26.8	42.23	36.92	44.4	23.55	26.1	22.31	36.54	52.5	52.74
EV/Sales	34.29	1.36	6.05	10.36	6.26	6.19	5.21	3.34	4.21	2.57	4.57	3.06	2.5	2.71	2.37
EV/EBITDA	- -	- -	90.67	24.27	12.06	16.21	16.12	9.75	14.24	18.46	51.74	28.51	11.14	23.8	12.15
Price/Earnings	- -	- -	- -	21.46	33.37	176.36	- -	33.93	119.83	- -	- -	- -	57.86	- -	20.51
Price/Earnings Average	-4.44	-2.01	-9.53	12.59	40.66	150.49	-574.78	45.11	131.83	-19.49	-10.27	-11.32	52.33	-58.41	19.1
Price/Earnings High	-7.66	-5.79	-24.95	23.38	54.38	206.32	-801.64	55.39	168.97	-36.18	-17.73	-15.85	69.14	-67.9	25.85
Price/Earnings Low	-0.72	-0.85	-5.21	7.05	26.73	77.97	-453.19	27.82	86.27	-12.5	-7.68	-7.33	38.34	-50.34	13.7
Price/Book Value	1.45	1.07	4.72	4.59	3.24	4.14	4.3	2.7	3.5	1.83	2.32	2.24	2.61	2.89	3.28
Price/Book Value Average	6.75	2.22	2.06	2.69	3.95	3.53	3.57	3.6	3.85	2.32	1.76	1.92	2.36	3.19	3.06
Price/Book Value High	11.65	6.4	5.4	5	5.28	4.84	4.98	4.42	4.94	4.3	3.04	2.69	3.12	3.7	4.14
Price/Book Value Low	1.1	0.94	1.13	1.51	2.6	1.83	2.82	2.22	2.52	1.49	1.32	1.24	1.73	2.75	2.19
Price/Tangible Book Value	1.45	1.07	6.73	6.7	5.65	-88.01	-13.2	-67.36	25.87	99.41	65.28	20.8	5.77	-5.89	-1,384.92
Price/Tangible Book Value Average	6.75	2.22	2.94	3.93	6.88	-75.1	-10.97	-89.56	28.46	125.77	49.43	17.83	5.22	-6.49	-1,289.85
Price/Tangible Book Value High	11.65	6.4	7.71	7.3	9.21	-102.97	-15.3	-109.96	36.47	233.43	85.32	24.95	6.9	-7.54	-1,745.62
Price/Tangible Book Value Low	1.1	0.94	1.61	2.2	4.53	-38.91	-8.65	-55.24	18.62	80.62	36.97	11.54	3.83	-5.59	-925.27
Price/Sales	113.05	11.63	3.38	11.02	6.72	5.39	4.21	2.61	3.54	1.67	2.69	2.07	2.04	1.74	1.79
Price/Sales Average	526.77	24.21	1.48	6.46	8.19	4.6	3.5	3.47	3.89	2.11	2.03	1.77	1.84	1.92	1.67
Price/Sales High	908.89	69.79	3.88	12.01	10.96	6.31	4.88	4.26	4.99	3.91	3.51	2.48	2.44	2.23	2.26
Price/Sales Low	85.91	10.21	0.81	3.62	5.39	2.38	2.76	2.14	2.55	1.35	1.52	1.15	1.35	1.65	1.2
Price/Cash Flow	-1.03	-1.06	-18.57	28	29.72	25.25	18.88	7.84	16	22.76	174.72	-20.96	8.34	16.68	8.55
Price/Cash Flow Average	-4.79	-2.2	-8.12	16.42	36.21	21.55	15.69	10.42	17.61	28.79	132.3	-17.97	7.55	18.38	7.96
Price/Cash Flow High	-8.26	-6.35	-21.27	30.5	48.43	29.55	21.88	12.79	22.57	53.44	228.36	-25.15	9.97	21.37	10.77
Price/Cash Flow Low	-0.78	-0.93	-4.44	9.2	23.81	11.17	12.37	6.43	11.52	18.45	98.96	-11.63	5.53	15.84	5.71
Price/Free Cash Flow Average	-4.86	-2.26	-8.42	6.33	12.72	3.39	4.2	9.04	11.16	5.26	16.3	-38.03	6.6	14.53	7.11
Price/Free Cash Flow High	-8.39	-6.51	-22.04	11.75	17.02	4.65	5.85	11.09	14.31	9.76	28.14	-53.21	8.72	16.89	9.62
Price/Free Cash Flow Low	-0.79	-0.95	-4.6	3.54	8.36	1.76	3.31	5.57	7.3	3.37	12.19	-24.6	4.84	12.53	5.1
EV/Sales Average	495.25	15.48	2.44	5.61	7.74	5.39	4.49	4.21	4.57	3.03	3.7	2.74	2.28	2.91	2.25
EV/Sales High	920.99	66.64	6.99	11.38	10.54	7.12	5.88	5.02	5.69	4.89	5.67	3.5	2.95	3.25	2.91
EV/Sales Low	4.06	- -	1.17	2.65	4.91	3.14	3.75	2.87	3.2	2.25	3.01	2.07	1.72	2.62	1.72
EV/EBITDA Average	-4.24	-1.55	36.56	13.15	14.92	14.11	13.9	12.29	15.46	21.73	41.88	25.55	10.15	25.59	11.5
EV/EBITDA High	-7.89	-6.69	104.66	26.67	20.31	18.64	18.21	14.63	19.25	35.1	64.22	32.65	13.15	28.57	14.88
EV/EBITDA Low	-0.03	0.02	17.47	6.21	9.45	8.22	11.59	8.36	10.82	16.13	34.12	19.26	7.66	23.05	8.79
EV/EBIT Average	-4.23	-1.54	81.76	15.7	18.07	25.88	27.17	24.02	57.45	-40.57	-28.37	-33.67	22.41	807.01	24.44
EV/EBIT High	-7.87	-6.62	234.02	31.84	24.6	34.19	35.6	28.59	71.52	-65.53	-43.51	-43.03	29.03	901.15	31.63
EV/EBIT Low	-0.03	0.02	39.05	7.42	11.45	15.09	22.66	16.33	40.19	-30.11	-23.12	-25.39	16.9	726.9	18.68
Last Price	18	7.38	20.08	56.39	45.12	60.62	64.45	45.02	61.67	29.04	46.08	40.23	55.14	55.28	78.94
High Price	144.72	44.28	23	61.43	73.54	70.92	74.7	73.49	86.96	68.19	60.23	48.26	65.89	70.81	99.5
Enterprise Value Average	216	36	73	314	591	693	794	849	944	632	799	867	1,110	1,790	1,985
Enterprise Value High	401	153	210	637	804	915	1,041	1,011	1,175	1,020	1,226	1,107	1,438	1,999	2,569
Enterprise Value Low	2	-1	35	148	374	404	662	578	660	469	651	653	837	1,612	1,518

Shares Outstanding	3	4	10	11	11	12	12	12	12	12	17	17	20	21	22
Diluted Weighted Avg Shares	3	4	5	11	12	12	12	12	12	12	13	16	18	19	21
Basic Weighted Avg Shares	3	4	5	11	11	11	12	12	12	12	13	16	18	19	20
Revenue per Share	0.16	0.63	5.93	5.12	6.71	11.24	15.31	17.26	17.44	17.43	17.16	19.46	27.04	31.8	44.05
EBITDA per Share	-18.58	-6.32	0.4	2.18	3.48	4.29	4.95	5.92	5.15	2.43	1.52	2.09	6.07	3.62	8.61
Operating Income per Share	-18.63	-6.39	0.18	1.83	2.88	2.34	2.53	3.03	1.39	-1.3	-2.24	-1.58	2.75	0.11	4.05
Basic EPS, GAAP	-18.88	-7.64	-0.92	2.63	1.35	0.34	-0.09	1.33	0.51	-1.88	-3.4	-3.05	0.95	-1.04	3.85
Basic EPS from Cont Ops	-18.88	-7.64	0.02	2.63	1.35	0.34	-0.09	1.33	0.51	-1.88	-3.38	-2.95	1.04	-0.96	3.91
Diluted EPS, GAAP	-18.88	-7.64	-0.92	2.6	1.33	0.34	-0.09	1.32	0.51	-1.88	-3.4	-3.05	0.94	-1.04	3.64
Diluted EPS from Cont Ops	-18.88	-7.64	0.02	2.6	1.33	0.34	-0.09	1.32	0.51	-1.88	-3.38	-2.95	1.03	-0.96	3.69
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.02	0.1	0.09	0.08	0.06
Cash Flow per Share	-17.52	-6.97	-1.08	2.01	1.52	2.4	3.41	5.74	3.85	1.28	0.26	-1.92	6.61	3.31	9.24
Free Cash Flow per Basic Share	-17.78	-7.14	-1.12	-1.25	-1.36	-10.62	-5.94	4.81	1.53	-4.43	-1.61	-2.93	5.58	2.44	7.53
Cash & Equivalents per Share	18.79	8.55	1.15	14.84	13.45	2.36	2.67	3.63	5.16	0.64	5.96	2.76	10.8	7.16	13.1
Book Value per Share	12.42	6.92	4.26	12.27	13.92	14.64	15	16.64	17.6	15.84	19.84	17.93	21.14	19.12	24.04
Tangible Book Value per Share	12.42	6.92	2.98	8.42	7.99	-0.69	-4.88	-0.67	2.38	0.29	0.71	1.93	9.55	-9.39	-0.06

ANI Pharmaceuticals, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)